Researchers in China studying IRLAB’s lead asset, mesdopetam (IRL790) in a preclinical model for lev...
Circio presents a scientific update on the pre-clinical work with the circular RNA platform.
Starkt kv2 2024 förväntas Fable Media Group AB (”FMG” eller ”Bolaget”) Meddelade på torsdagen den 1...
The announcement of the updated DFS for Dannemora showed, as expected, higher CAPEX and OPEX compare...
Redeye leaves a comment following Magle’s announcement of an acquisition of pK Biotech ApS and its s...
Redeye comments on GiG’s acquisition of the SEO and content service supplier Titan Inc, which is exp...
Redeye embraces the not-so-unanticipated SEK50m directed share issue, giving the company additional ...
Redeye initiates coverage of Coegin Pharma, a hub and spoke biotech company with a diverse array of ...
VEF är investmentbolaget som ger en unik möjlighet till att få exponering mot snabbväxande Fintech-b...
Luxbright AB (”Luxbright” eller ”Bolaget”) meddelade den 13 juni 2024 att Bolaget, med stöd av bemyn...
Redeye comments on the outcome of Episurf Medical’s rights issue of units that secured the company S...
We initiate coverage of Solwers, a company that acts as a growth platform for the built environment ...
Redeye in this note provides our first impressions on Acconeer’s CEO change that was announced yeste...
Redeye comments on SenzaGen’s directed issue, raising SEK37.
Redeye initiates coverage of WntResearch, a Swedish biotechnology company specialised in oncology.
Med ett nytt godkännande i Danmark för en THC/CBD medicinsk cannabisolja har Stenocare återtagit pos...
CirChem (”CirChem” eller ”Bolaget”) meddelade den 12 juni 2024 att Bolaget, efter ett framgångsrikt ...
Eastnine förvärvar en andra fastighet i polska Poznan och ökar hyresintäkterna med drygt 16% till 42...
Aptahem är ett bioteknikbolag som utvecklar ett läkemedel som har potential att definiera om behandl...
